Geode Capital Management’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.8M | Buy |
|
|||||
|
2025
Q1 | $2.52M | Buy |
|
|||||
|
2024
Q4 | $3.22M | Buy |
|
|||||
|
2024
Q3 | $6.31M | Buy |
|
|||||
|
2024
Q2 | $3.05M | Buy |
|
|||||
|
2024
Q1 | $3.01M | Buy |
|
|||||
|
2023
Q4 | $2.89M | Buy |
|
|||||
|
2023
Q3 | $2.13M | Buy |
|
|||||
|
2023
Q2 | $2.86M | Buy |
|
|||||
|
2023
Q1 | $2.39M | Buy |
|
|||||
|
2022
Q4 | $2.36M | Buy |
|
|||||
|
2022
Q3 | $3.16M | Buy |
|
|||||
|
2022
Q2 | $4.85M | Buy |
|
|||||
|
2022
Q1 | $5.33M | Buy |
|
|||||
|
2021
Q4 | $7.94M | Buy |
|
|||||
|
2021
Q3 | $3.8M | Buy |
|
|||||
|
2021
Q2 | $2.54M | Buy |
|
|||||
|
2021
Q1 | $1.93M | Buy |
|
|||||
|
2020
Q4 | $2.69M | Buy |
|